Germany· DE-A57-5131fddacbd686f8
Corvaton
A molsidomine product containing molsidomine, registered in Germany by Cheplapharm Arzneimittel Gmbh. The same ATC class is registered in 8 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Molsidomine is registered in 8 of 19 countries.
Countries holding a registration under ATC C01DX12 (molsidomine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 6 of them publish a price we can compare per daily dose
Molsidomine · ATC C01DX12
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Germany
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of molsidomine costs, country by country.
Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.33 in France to $0.63 in Switzerland — a ×1.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Molsidomine · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.63
- FR France$0.33
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Molsidomine
- Manufacturer
- Cheplapharm Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- C01DX12
- ATC class
- Molsidomine
- Defined daily dose
- 8 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for molsidomine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Molsidomine · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Molsidomine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceCORVASAL 2 mg, comprimé sécableCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- SwitzerlandCorvaton
- BelgiumCoruno 16 mgTherabel Pharma
- PolandMolsidomina WZFZakłady Farmaceutyczne POLPHARMA S.A.
- SpainMOLSIDAIN 2 mg COMPRIMIDOSCheplapharm Arzneimittel Gmbh
- United KingdomMolsidain 2mg tabletsImported (Spain)
- NorwayMolsidomin stadaStada
- CzechiaCORVATON FORTECHEPLAPHARM Arzneimittel GmbH, Greifswald
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Molsidolat
- Belgium · Coruno, Corvaton
- Bulgaria · Молсидомин Wzf, Сиднофарм
- Czechia · Corvaton Forte
- Spain · Molsidain
- France · Corvasal, Molsidomine Arrow
- Hungary · Corvaton, Corvaton Forte
- Lithuania · Molsidominum Pph
- Luxembourg · Coruno, Corvaton
- Poland · Molsidomina Wzf
- Slovakia · Corvaton, Corvaton Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/74a2cdac-4d6e-4d66-9db7-9cd7ae318f25 GET /v1/drugs/74a2cdac-4d6e-4d66-9db7-9cd7ae318f25?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Molsidomine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about molsidomine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.